Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Pacific Biosciences Of California (PACB) Construction in Progress (2016)

Pacific Biosciences Of California has reported Construction in Progress over the past 1 years, most recently at $5.8 million for Q4 2016.

For Q4 2016, Construction in Progress changed N/A year-over-year to $5.8 million; the TTM value through Dec 2016 reached $5.8 million, changed N/A, while the annual FY2016 figure was $5.8 million, N/A changed from the prior year.
Construction in Progress for Q4 2016 was $5.8 million at Pacific Biosciences Of California.
Over five years, Construction in Progress peaked at $5.8 million in Q4 2016 and troughed at $5.8 million in Q4 2016.